Sign up TODAY for ME/CFS Congressional Meetings from Home
We are pleased to announce that Advocacy Day congressional meetings will STILL take place on Tuesday, April 21 by remote online and phone systems.
Who can participate? US Citizens and residents
What will we do? Phone meetings with Congressional offices
What do I need? A phone or computer and your story.
When are the meetings? Tues. April 21, 2020 from 9am-5pm EST
When will I know if I have a meeting? No later than Friday, April 17
Deadline for Registration: Friday, March 27
Our team will provide you with training, materials, and a personalized schedule delivered by email no later than Friday April 17.
No experience? No problem! We will ensure every team has an experienced team member able to assist. Connect with other advocates from your State on the ME/CFS Advocacy Week and DC Lobby Day 2020 Facebook group.
*Important Note* We are unable to guarantee meeting participation due to the potential size of some conference calls. You will receive a personalized schedule by email or a notice that we are unable to accommodate your meeting request, no later than Friday April 17.
Stay tuned for more updates as we transition to online events. If you have any questions, please email our team at SolveCFS@SolveCFS.org
Please visit www.MEAdvocacyWeek.com for more information about additional events, online trainings and other opportunities.
Solve M.E. Partner Hosts Expert Webinar: Coronavirus Preparedness For People With Chronic Diseases
Date: Friday, March 13, 2020
Time: 12:00 p.m. ET/ 9:00 a.m. PT
COVID-19 is causing significant concerns globally. During this webinar, the speakers will discuss the ways patient groups can assist their members and other constituents in reducing the impact of COVID-19, such as how patients with chronic diseases can avoid the illness, what to do if they feel sick, and how patient groups can prepare to field inquiries from their members. This webinar will feature, Dr. Albert Rizzo, MD, FACP, Chief Medical Officer at the American Lung Association, and Dr. Stacie Bell, PhD, Chief Scientific & Medical Officer, National Psoriasis Foundation.
